The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
The effect of age upon liver volume and apparent liver blood flow in healthy man
Open accessAbstract
The aim of this study was to determine the effect of aging upon liver volume and apparent liver blood flow in healthy man. Sixty-five subjects between 24 and 91 years of age were recruited. Liver volume was quantitated by a gray scale B ultrasound scan method. Apparent liver blood flow was determined from the plasma clearance of indocyanine green, based on an assumption of no change in hepatic extraction of the dye with age. A significant negative correlation was observed between age and both liver volume and apparent liver blood flow (p <0.001), whether expressed in absolute terms or per unit body weight. Similarly, a significant negative correlation was observed between apparent liver blood flow per unit volume of liver (liver perfusion) and age (p<0.005). The reduction in liver volume, apparent liver blood flow and perfusion may at least partly account for the decline in the clearance of many drugs undergoing liver metabolism which has been noted to occur with aging in man.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
INDOCYANINE GREEN: OBSERVATIONS ON ITS PHYSICAL PROPERTIES, PLASMA DECAY, AND HEPATIC EXTRACTION*
Cherrick, G. R., Stein, S. W., Leevy, C. M., & Davidson, C. S. (1960) · Journal of Clinical Investigation · doi:10.1172/jci104072 · Cited by 979
CAESAR, J., Shaldon, S., Chiandussi, L., Guevara, L., & Sherlock, S. (1961) · PubMed · Cited by 761
Greenblatt (1982) · doi:10.1056/nejm198205063061804 · Cited by 584
ESTIMATION OF HEPATIC BLOOD FLOW WITH INDOCYANINE GREEN*
Leevy, C. M., Mendenhall, C. L., Lesko, W., & Howard, M. M. (1962) · Journal of Clinical Investigation · doi:10.1172/jci104570 · Cited by 380
Pharmacokinetics in the Elderly
Crooks, J., OʼMalley, K., & Stevenson, I. H. (1976) · Clinical Pharmacokinetics · doi:10.2165/00003088-197601040-00003 · Cited by 342
Antipyrine metabolism in man: Influence of age, alcohol, caffeine, and smoking
Vestal, R. E., Norris, A. H., Tobin, J. D., Cohen, B. H., Shock, N. W., & Andres, R. (1975) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1975184425 · Cited by 318
The effect of ageing on the hepatic clearance of propranolol.
Castleden, C., & George, C. (1979) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1979.tb00896.x · Cited by 247
KINETICS OF INDOCYANINE GREEN REMOVAL FROM THE BLOOD*
Paumgartner, G., Probst, P., Kraines, R., & Leevy, C. M. (1970) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1970.tb37009.x · Cited by 216
Effects of age and cigarette smoking on propranolol disposition
Vestal, R. E., Wood, A. J. J., Branch, R. A., Shand, D. G., & Wilkinson, G. R. (1979) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt19792618 · Cited by 186
In vivo hepatic volume determination using sonography and computed tomography
Van Thiel, D. H., Hagler, N. G., Schade, R. R., Skolnick, M. L., Heyl, A. P., Rosenblum, E., Gavaler, J. S., & Penkrot, R. J. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90005-8 · Cited by 166
Cited by
Mangoni, A. A., & Jackson, S. H. D. (2004) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.02007.x · Cited by 1,874
Aging Biology and Geriatric Clinical Pharmacology
McLean, A. J., & Le Couteur, D. G. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.4 · Cited by 771
Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c
Poynard, T., Ratziu, V., Charlotte, F., Goodman, Z., McHutchison, J., & Albrecht, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00097-0 · Cited by 749
Almazroo, O. A., Miah, M. K., & Venkataramanan, R. (2017) · Clinics in Liver Disease · doi:10.1016/j.cld.2016.08.001 · Cited by 681
Body surface area and body weight predict total liver volume in Western adults
Vauthey, J.-N., Abdalla, E. K., Doherty, D. A., Gertsch, P., Fenstermacher, M. J., Loyer, E. M., Lerut, J., Materne, R., Wang, X., Encarnacion, A., et al. (2002) · Liver Transplantation · doi:10.1053/jlts.2002.31654 · Cited by 637
Adverse drug reactions in special populations – the elderly
Davies, E. A., & O'Mahony, M. S. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12596 · Cited by 604
Kim, I. H., Kisseleva, T., & Brenner, D. A. (2015) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000176 · Cited by 497
Age-related changes in liver structure and function: Implications for disease ?
Schmucker, D. L. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.06.009 · Cited by 481
A comparison of fibrosis progression in chronic liver diseases
Poynard, T., Mathurin, P., Lai, C.-L., Guyader, D., Poupon, R., Tainturier, M.-H., Myers, R. P., Muntenau, M., Ratziu, V., Manns, M., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00413-0 · Cited by 474
Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases
(2018) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2018.05.006 · Cited by 455
Gorski, J. C., Jones, D. R., Haehner-Daniels, B. D., Hamman, M. A., O'Mara, E. M., & Hall, S. D. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90146-1 · Cited by 411
Ischaemia reperfusion injury in liver transplantation: Cellular and molecular mechanisms
Dar, W. A., Sullivan, E., Bynon, J. S., Eltzschig, H., & Ju, C. (2019) · Liver International · doi:10.1111/liv.14091 · Cited by 397
Management of drug therapy in the elderly
Desforges, J. F., Montamat, S. C., Cusack, B. J., & Vestal, R. E. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908033210507 · Cited by 388
PARKINSON, A. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.01.010 · Cited by 386
Aging Biomarker Consortium, Bao, H., Cao, J., Chen, M., Chen, M., Chen, W., Chen, X., Chen, Y., Chen, Y., Chen, Y., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2305-0 · Cited by 376
Risk Factors for Idiosyncratic Drug-Induced Liver Injury
Chalasani, N., & Björnsson, E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.001 · Cited by 347
Changes in liver volume from birth to adulthood: A meta-analysis
Johnson, T. N., Tucker, G. T., Tanner, S. M., & Rostami-Hodjegan, A. (2005) · Liver Transplantation · doi:10.1002/lt.20519 · Cited by 324
The Aging Liver: Drug Clearance and an Oxygen Diffusion Barrier Hypothesis
Le Couteur, D. G., & McLean, A. J. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199834050-00003 · Cited by 308
Lean Body Mass as a Predictor of Drug Dosage: Implications for Drug Therapy
Morgan, D. J., & Bray, K. M. (1994) · Clinical Pharmacokinetics · doi:10.2165/00003088-199426040-00005 · Cited by 299
Yang, J., Fernández-Galilea, M., Martínez-Fernández, L., González-Muniesa, P., Pérez-Chávez, A., Martínez, J. A., & Moreno-Aliaga, M. J. (2019) · Nutrients · doi:10.3390/nu11040872 · Cited by 292
The Influence of Age and Sex on the Clearance of Cytochrome P450 3A Substrates
Cotreau, M. M., von Moltke, L. L., & Greenblatt, D. J. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544010-00002 · Cited by 292
Differential Induction of Prehepatic and Hepatic Metabolism of Verapamil by Rifampin
Fromm, M. F., Busse, D., Kroemer, H. K., & Eichelbaum, M. (1996) · Hepatology · doi:10.1002/hep.510240407 · Cited by 283
Pharmacokinetics in older persons
Cusack, B. J. (2004) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2004.12.005 · Cited by 253
Drug-induced liver injury: a comprehensive review
Hosack, T., Damry, D., & Biswas, S. (2023) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848231163410 · Cited by 214
An On-Chip Small Intestine–Liver Model for Pharmacokinetic Studies
Kimura, H., Ikeda, T., Nakayama, H., Sakai, Y., & Fujii, T. (2015) · SLAS Technology · doi:10.1177/2211068214557812 · Cited by 136
“The blood flow ratio of the portal vein to the hepatic artery and the organ volume ratio of the small intestine to the liver in the human body are approximately 3:1 and 2:1, respectively.(24,25) The parameters for the microchannels on the PDMS chips were adjusted and calculated to balance the pressure drop between the…”
BackgroundBasal Activity of Kupffer Cells Increases With Old Age
Hilmer, S. N., Cogger, V. C., & Couteur, D. G. L. (2007) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/62.9.973 · Cited by 113
Role of Oxidative Stress in Liver Disorders
Conde de la Rosa, L., Goicoechea, L., Torres, S., Garcia-Ruiz, C., & Fernandez-Checa, J. C. (2022) · Livers · doi:10.3390/livers2040023 · Cited by 107
Pharmacokinetics of methylprednisolone in elderly and young healthy males
Tornatore, K. M., Logue, G., Venuto, R. C., & Davis, P. J. (1994) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1994.tb06219.x · Cited by 38
“:" The slower clearances observed in our elderly subjects may be attributed to an age-related decline in liver mass and/or a decrease in the oxidative processes within the liver.(22), 23 It has been documented previously with antipyrine, a model drug for studying hepatic oxidative metabolism, that reduction of the hep…”
BackgroundCao, X., & Thyfault, J. P. (2023) · Experimental Gerontology · doi:10.1016/j.exger.2023.112178 · Cited by 25
Metadata
- Authors
- Wynne, H. A., Cope, L. H., Mutch, E., Rawlins, M. D., Woodhouse, K. W., & James, O. F. W.
- Venue
- Hepatology
- Published
- 1989-02
- Volume
- 9
- Issue
- 2
- Pages
- 297-301
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1992268549
- Cited by
- 652
- References
- 23
- FWCI
- 10.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.